Researcher Profile

Researcher Profile

Kentaro Minagawa, MD, PhD

Kentaro Minagawa, MD, PhD

Assistant Professor, Department of Medicine
Division of Hematology and Oncology
Scientific Program:Next-Generation Therapies
kxm892@psu.edu

Research Interests

  • Therapeutics
  • Bone Marrow
  • T-Lymphocytes
  • Genes
  • Neoplasms
  • Mycophenolic Acid
  • Hematopoietic Stem Cell Transplantation
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Transplants
  • Hematopoietic Stem Cells
  • Follicular Lymphoma

Recent Publications

2021

Tomita, T, Kato, M, Mishima, T, Matsunaga, Y, Sanjo, H, Ito, KI, Minagawa, K, Matsui, T, Oikawa, H, Takahashi, S, Takao, T, Iwai, N, Mino, T, Takeuchi, O, Maru, Y & Hiratsuka, S 2021, 'Extracellular mRNA transported to the nucleus exerts translation-independent function', Nature communications, vol. 12, no. 1, 3655. https://doi.org/10.1038/s41467-021-23969-1
Ishii, S, Suzuki, T, Wakahashi, K, Asada, N, Kawano, Y, Kawano, H, Sada, A, Minagawa, K, Nakamura, Y, Mizuno, S, Takahashi, S, Matsui, T & Katayama, Y 2021, 'FGF-23 from erythroblasts promotes hematopoietic progenitor mobilization', Blood, vol. 137, no. 11, pp. 1457-1467. https://doi.org/10.1182/blood.2020007172
Shah, N, Rakszawski, K, Nickolich, M, Ehmann, C, Wirk, B, Naik, S, Rybka, W, Zheng, H, Mierski, J, Silar, B, Mackey, G, Greiner, R, Brown, V, Claxton, D, Mineishi, S & Minagawa, K 2021, 'Improved outcome in AML relapse after allogeneic transplant with high-intensity chemotherapy followed by 2nd allogeneic stem cell transplant or donor lymphocyte infusion', Annals of Hematology, vol. 100, no. 10, pp. 2585-2592. https://doi.org/10.1007/s00277-021-04616-7
Suzuki, T, Ishii, S, Shinohara, M, Kawano, Y, Wakahashi, K, Kawano, H, Sada, A, Minagawa, K, Hamada, M, Takahashi, S, Furuyashiki, T, Tan, NS, Matsui, T & Katayama, Y 2021, 'Mobilization efficiency is critically regulated by fat via marrow PPARd', Haematologica, vol. 106, no. 6, pp. 1671-1683. https://doi.org/10.3324/haematol.2020.265751
Jamy, O, Innis-Shelton, R, Bal, S, Paluri, R, Salzman, D, Di Stasi, A, Costa, L, Meredith, R, Lamb, L, Minagawa, K, Mineishi, S & Saad, A 2021, 'Phase II clinical trial of one dose of post-transplant cyclophosphamide for graft versus host disease prevention following myeloablative, peripheral blood stem cell, matched-unrelated donor transplantation', American Journal of Hematology, vol. 96, no. 10, pp. E396-E398. https://doi.org/10.1002/ajh.26296

2019

Minagawa, K, Al-Obaidi, M & Di Stasi, A 2019, Generation of suicide gene-modified chimeric antigen receptor-redirected T-cells for cancer immunotherapy. in Methods in Molecular Biology. Methods in Molecular Biology, vol. 1895, Humana Press Inc., pp. 57-73. https://doi.org/10.1007/978-1-4939-8922-5_5
Wakahashi, K, Minagawa, K, Kawano, Y, Kawano, H, Suzuki, T, Ishii, S, Sada, A, Asada, N, Sato, M, Kato, S, Shide, K, Shimoda, K, Matsui, T & Katayama, Y 2019, 'Vitamin D receptor–mediated skewed differentiation of macrophages initiates myelofibrosis and subsequent osteosclerosis', Blood, vol. 133, no. 15, pp. 1619-1629. https://doi.org/10.1182/blood-2018-09-876615

2018

Wakahashi, S, Kawakami, F, Wakahashi, K, Minagawa, K, Matsuo, K, Katayama, Y, Yamada, H, Matsui, T & Sudo, T 2018, 'Transformed Follicular Lymphoma (TFL) predicts outcome in advanced endometrial cancer', Cancer Epidemiology Biomarkers and Prevention, vol. 27, no. 8, pp. 963-969. https://doi.org/10.1158/1055-9965.EPI-17-0762

Clinical Trials Search


Children (age < 18 years)
Adults (age >= 18 years)